CERO US EQUITY Health Care Health Care CIK: 1870404

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Quant Factor Diagnostic & Fair Value Model

CERO THERAPEUTICS HOLDINGS, INC. (Ticker: CERO) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$0.01
-94.74% Latest Close (2026-10-23)
Market Cap: $344,000.00
P/E Ratio: -
Momentum Strength 3M / 12M
-99.94%
1M: -99.91% 12M: 0.00%
Quality (ROE) Point-in-Time
-
Trailing Return on Equity
Technical Trend RSI 14
12.0
SMA50: $4.36 SMA200: $6.25
Valuation Multiplier Trailing
-
Pre-Profit / Negative TTM
📊 Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM

CERO has negative or near-zero trailing GAAP earnings over the trailing twelve months.

⚡ Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1870404 · 10-K 年报 / 10-Q 季报
Form Period End Filing Timestamp (Point-in-Time) Revenue Net Income Operating CF EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1870404

💡 Methodology & Frequently Asked Questions

Key reference details regarding CERO THERAPEUTICS HOLDINGS, INC. (CERO) valuation multiples, momentum factors, and point-in-time filing conventions.

How should CERO's current valuation multiple be interpreted? ↓
CERO trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are CERO's key momentum and technical factor indicators? ↓
As of the latest close, CERO shows a 1-month return of -99.91%, 3-month return of -99.94%, and 12-month return of 0.00%, with a 14-day RSI of 12.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for CERO? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can CERO be incorporated into systematic factor models? ↓
CERO can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.

Related Peers & Valuation Comparison in Health Care

Dense Internal Network Mesh